Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-02-28

Clinical Trial Update: Establishing of Neuronal-like Cells From Patients With Cisplatin-Induced Peripheral Neuropathy

View source ↗

Summary

The clinical trial NCT02492360 that aimed to establish neuronal-like cells from patients with cisplatin-induced peripheral neuropathy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Costantine Albany | Conditions: Peripheral Nervous System Diseases, Testicular Neoplasms | Status: WITHDRAWN